"I didn't realize my new pharmacy's compounded medication had a different concentration," shares Robert, who experienced an accidental overdose. "I used the same syringe markings I always did, but ended up injecting nearly double the dose because the concentration was higher." This common scenario highlights why understanding medication concentrations, proper syringe selection, and dose calculations is crucial for GLP-1 safety.

To help prevent dosing errors and maintain accurate records, use our GLP-1 Plotter to track your prescribed medication schedule and doses.

Understanding Concentration Risks

GLP-1 medication overdose most commonly occurs due to concentration mismatches between different sources or incorrect syringe selection. Dr. Sarah Chen, an endocrinologist specializing in GLP-1 treatments, explains: "The rise in compounded options has introduced variable concentrations into the market. A patient might be used to drawing to the 0.25mL mark with one concentration, but that same mark could deliver a much higher dose with a different concentration. This is why understanding your specific medication's concentration and using the correct syringe type is critical."

Common Overdose Scenarios

  • Different concentration from new pharmacy
  • Wrong syringe type for concentration
  • Misreading unit markings vs mL markings
  • Confusion between U-100 and other scales

Recognizing Overdose Symptoms

The symptoms of GLP-1 overdose typically appear within hours of administration and can range from uncomfortable to severe. Understanding these signs is crucial for proper response. The Track IQ tool can help document symptoms and timing for medical professionals, though immediate medical attention should always be the priority.

Warning Signs

  • Immediate Signs: Severe nausea, vomiting, dizziness
  • Critical Signs: Severe stomach pain, fainting, rapid heartbeat
  • Metabolic Signs: Low blood sugar (below 70 mg/dL or 3.9 mmol/L)
  • Digestive Signs: Intense cramping, severe diarrhea

Immediate Action Steps

Microdose Tools & Resources

Disclaimer: GLP1Microdose.com is independent and not affiliated with Novo Nordisk, Eli Lilly, or any pharmaceutical manufacturer. Microdosing protocols are not FDA-approved dosing regimens. This article is educational only and does not constitute medical advice.